摘要
目的:通过分析,了解某院新型冠状病毒感染肺炎(NCP)治疗期间药品不良反应(ADR)发生特点及分布情况,促进医院采取相应措施,临床合理、安全用药。方法:对某院14例ADR报告进行分类统计分析。结果:新型冠状病毒感染肺炎(NCP)治疗期间发生ADR的药品以抗菌药物、中药注射剂血必净居多,给药途径以静脉给药为主,ADR主要表现为皮肤及其附件的红斑疹、瘙痒。结论:药师应提升处方审核能力,关注临床ADR,保障患者用药安全,充分发挥临床药师在临床药物指导方面的作用。
Objective:To analyze and understand the characteristics and distribution of adverse drug reactions(ADR)during the COVID-19 treatment in our hospital,and took corresponding measures to promote our hospital’s clinically reasonable and safe medication.Methods:The 14 cases of ADR report in our hospital were classified and analyzed.Results:The drugs causing ADR were mainly antibacterial drugs and traditional Chinese medicine injection of Xuebijing,and the main route of administration was intravenous.ADR results were mainly manifested in erythema and itching of the skin and its accessories.Conclusion:Pharmacists should enhance the ability to review prescriptions,pay attention to clinical ADR,and ensure the safety of patients’medication,so as to give full play to the role of clinical pharmacists in clinical drug treatment.
作者
王双艳
黄德红
王春国
Wang Shuangyan;Huang Dehong;Wang Chunguo(Chinese Medicine Hospital of Xiangyang,Xiangyang 441000,China;Scientific Research and Test Center,Beijing University of Chinese Medicine,Beijing 100029,China)
出处
《亚太传统医药》
2021年第2期206-208,共3页
Asia-Pacific Traditional Medicine
基金
国家自然科学基金青年基金(81703744)
